Targets Pre-Seed/Seed for women, minorities and veterans and formative-stage local/regional/global emerging ventures, prioritizing underrepresented founders with a 50/50 gender split and 100% minority co-founder representation. The firm continues to build its presence across the venture capital landscape.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Is dedicated to impactful businesses aiming to positively transform the world's food system.
Formative-stage investor oriented toward AI-driven health, mobility, fintech/insurtech and intelligent enterprise, delivering hands-on GTM and roadmap support from ex-corporate venture leaders and engineers leveraging Allianz's risk, data, and regulatory expertise. With a disciplined investment approach, the team drives value for both founders and investors.
Spearheaded by a former Google X founder, the firm brings a moonshot lab prototyping philosophy anchored in a structured Triad investment thesis encompassing deep technology, reimagined unit economics, and climate-positive outcomes. It stands out by offering hands-on prototyping assistance and reverse-engineering of unit-economics models for its portfolio.
Targets concept-stage software-plus-physical goods emerging ventures, acting as a hands-on product partner with veteran hardware engineers, a million-dollar prototyping shop, and direct guidance on design, manufacturing and fundraising. With a disciplined investment approach, the team drives value for both founders and investors.
Deliberate 60/40 tech/healthcare split dedicated to de novo company formation, with a transparent debate-driven partner scoring system (1–4) and proven multi-generation continuity. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
Invests at the concept stage, co-founding and building breakthrough life sciences and deep-science platforms directly with university researchers, acting as a company-builder partner to commercialize frontier biology. With a disciplined investment approach, the team drives value for both founders and investors.
